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Abstract
Objectives: Increasingly, surgeons are performing hepatectomies in older patients. This study was
designed to analyse the incidences of and risk factors for post-hepatectomy morbidity and mortality in
elderly patients.
Methods: All elective hepatectomies for the period 2005–2010 recorded in the American College of
Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) database were evaluated.
Factors associated with 30-day rates of morbidity and mortality were compared between patients aged
75 years and those aged <75 years.
Results: Elderly patients accounted for 894 of 7621 (11.7%) hepatectomies. These patients more
frequently had comorbidities (diabetes, cardiovascular or lung disease, lower albumin, elevated creati-
nine, anaesthesia risk; all P < 0.05) and were more likely to undergo partial or left rather than right or
extended hepatectomies (P = 0.013). Despite the lesser surgical magnitude of these procedures, elderly
patients experienced higher rates of severe complications (23.9% versus 18.4%; P < 0.001) and overall
postoperative mortality (4.8% versus 2.0%; P < 0.001). The occurrence of any severe complication was
associated with a mortality rate of 20.1% in elderly patients and 10.8% in non-elderly patients (P < 0.001).
This disparity in mortality was more pronounced in patients with two or more (31.7% versus 20.2%; P <
0.001) and three or more (46.3% versus 31.1%; P < 0.001) severe complications. Independent risk factors
for severe complications and/or mortality included an albumin level of < 4 g/dl, lung disease, intraopera-
tive transfusion, a concurrent intra-abdominal operation, and an operative time of >240 min (all P < 0.05).
Conclusions: Given their lower physiologic reserve, elderly patients are at much greater risk for mortality
after severe complications. To improve outcomes, surgeons should balance age and preoperative comor-
bidities with magnitude of hepatectomy.
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Introduction
Over the past three decades, as post-hepatectomy mortality rates
have improved, surgeons have extended the limits of tumour
resectability and patient medical fitness for liver resection. Cur-
rently, expected mortality rates for all but the most complex hepa-
tectomies are reported to be < 2.5%1 and fall to < 1% at specialized
centres of excellence.2–4 These favourable outcomes are the result
of improvements in patient selection,1 optimization of the future
liver remnant with portal vein embolization,5 limiting preopera-
tive chemotherapy duration,6,7 advanced surgical techniques,8
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specialized perioperative care,9 personalized multidisciplinary
treatment sequencing,10–13 and improved strategies for rescue in
the event of complications.14 Given these advances, surgeons are
increasingly considering elderly patients as potential candidates
for liver surgery.
Past single-institution studies have suggested that it is safe
to perform major hepatopancreatobiliary surgery in elderly
patients.15,16 These reports suggested equivalent morbidity and
mortality rates in elderly and matched non-elderly patients, but
close inspection reveals that the similarity between study groups
was the result of patient selection bias and limits on the magni-
tude of procedures performed in the elderly patient group.17 In
contrast to these studies, larger studies based on multi-institution
national databases have demonstrated that older age is an inde-
pendent risk factor for morbidity and mortality after major
abdominal surgery.9,18–20 Thus, the use of the American College of
Surgeons (ACS) National Surgical Quality Improvement Program
(NSQIP) database, which samples patients from over 400 hospi-
tals of various sizes and academic or private backgrounds, might
be expected to provide a more generalizable view of surgical out-
comes, potentially avoiding some of the traditional limitations
and biases of single-institution studies.20–22
The hypothesis of the present study was that elderly patients, in
comparison with their non-elderly counterparts, were at greater
risk for post-hepatectomy morbidity and mortality. To address
this question, the current study was designed to analyse national
rates of post-hepatectomymorbidity andmortality in the growing
population of elderly patients and to compare these with rates in
non-elderly patients. Within this context, the primary study aim
was to identify risk factors for morbidity and mortality in order to
find potentially modifiable risk factors and to suggest methods by
which surgeons might improve surgical outcomes in elderly
patients undergoing hepatectomy.
Materials and methods
Data acquisition and patients
All hepatectomy procedures recorded in the ACS-NSQIP Partici-
pant Use File for 2005–2010 were identified. Emergency opera-
tions and wedge resections [current procedural terminology
(CPT) code 47100] were excluded and all remaining elective hepa-
tectomies were included for analysis. The extent of hepatectomy
was classified by the primary CPT code and included the following
liver resections in order of increasing magnitude: partial (CPT
47120); left (47125); right (47130), and extended (47122) hepate-
ctomies. Risk factors for major morbidity and mortality were
derived from an analysis of NSQIP-collected perioperative clinical
factors, as previously described.1,23
The preoperative NSQIP-collected variables assessed included
age, race, sex, weight, body mass index, albumin, haematocrit,
platelets, white blood cell count, partial thrombin time, interna-
tional normalized ratio, blood urea nitrogen, creatinine, alkaline
phosphatase, aspartate aminotransferase, bilirubin, performance
status, American Society of Anesthesiologists (ASA) class,
smoking status, chronic obstructive pulmonary disease (COPD),
pneumonia, sepsis, disseminated cancer, diabetes, bleeding disor-
der, ascites, preoperative transfusion, previous operation within
30 days, preoperative hospitalization, preoperative chemotherapy,
and preoperative radiation therapy.
Intraoperative variables included in the analysis were intraop-
erative transfusion, extent of hepatectomy, operative time, con-
current major surgery and radiofrequency ablation. Concurrent
major operations included gastrointestinal resection or anasto-
mosis, biliary resection or reconstruction, thoracic operation, and
ventral hernia repair. The definition of major operations excluded
cholecystectomy, vena cava repair, diaphragm repair, lym-
phadenectomy and diagnostic laparoscopy.
Analysed postoperative outcomes included transfusion, bleed-
ing transfusion (transfusion of >4 units of blood within 72 h after
surgery), renal insufficiency or failure, respiratory failure, return
to the operating room (ROR), cardiac arrest, stroke, coma, myo-
cardial infarction, pneumonia, postoperative sepsis or septic
shock, surgical site infection, organ space infection (OSI), fascial
dehiscence, length of stay, and 30-day mortality.
Definitions
Elderly patients were defined as those aged75 years; non-elderly
patients were defined as those aged < 75 years. This cut-off was
chosen based on past NSQIP studies on elderly cancer surgery
patients, as well as in order to define a statistically analysable
cohort of at least 10% of all patients based on the age distribution
around the national median age of hepatectomy patients.20 Post-
hepatectomy ‘severe’ complications, or major morbidity, included
occurrences of the following NSQIP-collected variables: OSI;
dehiscence; re-intubation; ventilator dependence or failure to
wean for >48 h; acute renal insufficiency or failure; pneumonia;
stroke; coma; cardiac arrest; myocardial infarction; venous throm-
boembolism; sepsis or septic shock; ROR, and death. In general,
therapeutic interventions to manage each of these complications
would classify them as being of at least Grade II and frequently as
of Grade III or IV in severity.24 Based on the follow-up limits
intrinsic to NSQIP data collection, post-hepatectomy mortality
was defined as death within 30 days of surgery or death at a later
date if the patient’s hospital admission extended from surgery to
the date of mortality.
Statistical analysis
The relationships between risk factors (comorbidities, extent of
hepatectomy, age) and outcomes (severe complications, mortal-
ity) were compared for non-elderly and elderly patients. The chi-
squared test or Fisher’s exact test were used to compare categorical
data. The Mann–Whitney U-test was used to compare non-
parametric continuous data. After univariate analysis, significant
risk factors (P < 0.05 and >1% of all patients) were entered into
a multivariate logistic regression model to determine independ-
ent associations with study outcomes. Statistical analyses were
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performed using spss Statistics 19 (IBM Corp., Armonk, NY,
USA). All tests were two-sided. Statistical significance was indi-
cated by a P-value of < 0.05.
Results
Patients, age distribution, comorbidities and extent
of hepatectomy
Of the 7621 hepatectomy patients who met the study inclusion
criteria, 894 (11.7%) were aged 75 years; 847 (11.1%) patients
were aged 70–74 years, 2135 (28.0%) were aged 60–69 years, 1920
(25.2%) were aged 50–59 years, and 1825 (23.9%) were aged < 50
years. Elderly patients were more likely to have the following char-
acteristics: poor performance status; diabetes; dyspnoea; history
of stroke; cardiopulmonary disease; lower protein levels; uraemia;
elevated creatinine; thrombocytopenia, and an ASA class of 3
(Table 1). Only 129 of 7621 (1.7%) study patients were noted to
have symptomatic chronic liver disease, including the presence of
ascites and/or varices. Regarding the magnitude of surgery, elderly
patients had shorter median operative times. In accordance with
the differences in operative times, elderly patients were slightly less
likely to undergo right or extended hepatectomies (Fig. 1). Elderly
patients were more likely to undergo surgery for malignant diag-
noses. However, elderly and non-elderly patients underwent
similar rates of concomitant major surgery [114/894 (12.8%)
versus 805/6727 (12.0%); P = 0.500]. Based on an expansion in the
number of hospitals contributing data to the NSQIP over time,
half of all the elderly patients in this study (447 of 894) were
operated upon during 2005–2008 and represented 11.3% (447 of
3968) of all liver resection patients. The other half were operated
upon during 2009–2010 and accounted for 12.2% (447 of 3653) of
all liver resection patients, which does not indicate a trend towards
an increased proportion of elderly subjects in the later time period
(P = 0.188).
Severe complications after hepatectomy
Despite lower frequencies of comorbidities and the lesser magni-
tude of surgeries, elderly patients more frequently experienced
severe complications (Fig. 2).Major morbidity rates were strongly
associated with the magnitude of hepatectomy in elderly patients:
severe complication rates for extended, right, left and partial hepa-
tectomies were 34.1% (28/82), 32.9% (50/152), 23.8% (24/101)
and 20.0% (112/559), respectively (Fig. 2). The univariate analysis
of risk factors associated with severe complications in elderly
patients is detailed in Table 2. In multivariate analysis, risk factors
independently associated with severe complications were COPD
[odds ratio (OR) 3.12, 95% confidence interval (CI) 1.53–6.33;
P = 0.002], intraoperative transfusion (OR 2.43, 95% CI 1.61–
3.68; P < 0.001), operative time of >240 min (OR 2.76, 95% CI
1.82–4.18; P = 0.047) and concomitant major abdominal surgery
(OR 2.24, 95% CI 1.31–3.82; P = 0.003).
Mortality after hepatectomy
The overall post-hepatectomy mortality rate was 2.0%. Mortality
rates in all patients according to the extent of hepatectomy corre-
lated with the magnitude of hepatectomy [extended: 4.8% (37/
772); right: 3.7% (56/1494); left: 1.0% (8/802); partial: 1.7% (76/
4553); P < 0.001]. Compared with non-elderly patients, elderly
patients experienced a higher overall 30-day mortality rate [4.8%
(43/894) versus 2.0% (134/6727); P < 0.001] (Fig. 3). The age-
related mortality rate difference was most pronounced after
extended [9.8% (8/82) versus 4.2% (29/690); P < 0.001] and right
[9.9% (15/152) versus 3.1% (41/1342); P < 0.001] hepatectomies
(Fig. 3). Mortality rates in elderly patients did not differ signifi-
cantly between the early and late portions of the study period
[3.8% (17/447) versus 5.8% (26/447); P = 0.160]. The univariate
analysis of risk factors associated with mortality in elderly patients
is documented in Table 3. Independently associated risk factors
for mortality in elderly patients identified in multivariate analysis
included an albumin level of < 4 g/dl (OR 2.85, 95% CI 1.20–6.74;
P = 0.017), intraoperative transfusion (OR 2.37, 95% CI 1.01–
5.54; P = 0.047) and operative time of >240 min (OR 4.02, 95% CI
1.60–10.06; P = 0.008).
Failure to rescue: post-complication mortality in
elderly patients
Severe complications resulted in mortality rates of 20.1% (43 of
214) in elderly patients and 10.8% (134 of 1236) in non-elderly
patients (P < 0.001) (Fig. 4). As the number of severe complica-
tions increased, ability to clinically rescue patients (i.e. prevent
mortality after complications) declined. As the burden (number)
of severe complications increased, mortality rates were always at
least 10 absolute percentage points higher in elderly patients
[46.3% (37/80) versus 31.1% (105/338) in patients with three or
more severe complications; P < 0.001] (Fig. 4).
Discussion
Several convergent factors have increased the number of elderly
patients considered for hepatectomy. Firstly, according to the 2010
US Census, population numbers increased at a faster rate in older
age groups than in younger age groups over the past decade and
a further spike in the elderly population is anticipated as
baby-boomers grow older.25 Secondly, rates of most primary and
secondary liver cancers increase with age.26 Thirdly, the aforemen-
tioned advances in perioperative care and surgical technique have
improved the safety of hepatic resection and expanded the defi-
nition of an operable patient.6,14,27 Given these factors, this study
was designed to test the hypothesis that elderly patients are at
greater risk for post-hepatectomy morbidity and mortality. This
analysis confirmed that elderly patients experienced more than
double the risk for 30-day mortality of non-elderly patients and
that this is mostly attributable to a higher rate of mortality after
serious complications.
These data differ from those of some previously published
single-institution studies which concluded there was no elevation
in age-related risk, but which may have been (appropriately)
biased by patient selection.16,17 Through the examination of a
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Table 1 Preoperative differences between elderly (75 years) and non-elderly (<75 years) hepatectomy patients
Clinical characteristic All patients Non-elderly patients Elderly patients P-value
Patients, n (%) 7621 (100%) 6727 (88.3%) 894 (11.7%)
Preoperative factors, n (%)
Race, White 5735 (75.3%) 5028 (74.7%) 707 (79.1%) 0.005
Gender, male 3690 (48.4%) 3206 (47.7%) 484 (54.1%) <0.001
Diabetes 1223 (16.0%) 1012 (15.0%) 211 (23.6%) <0.001
Dyspnoea 669 (8.8%) 566 (8.4%) 103 (11.5%) 0.002
Lack of independent function 148 (1.9%) 122 (1.8%) 26 (2.9%) 0.026
History of stroke 161 (2.1%) 119 (1.8%) 42 (4.7%) <0.001
COPD 239 (3.1%) 185 (2.8%) 54 (6.0%) <0.001
Previous coronary stent 322 (4.2%) 233 (3.5%) 89 (10.0%) <0.001
Previous cardiac surgery 303 (4.0%) 216 (3.2%) 87 (9.7%) <0.001
Medical hypertension 3595 (47.2%) 2969 (44.1%) 626 (70.0%) <0.001
Albumin < 4 g/dl 2837 (37.2%) 2426 (36.1%) 411 (46.0%) <0.001
INR >1.0 2656 (34.9%) 2269 (33.7%) 387 (43.3%) <0.001
Haematocrit < 39% 3435 (45.1%) 2987 (44.4%) 448 (50.1%) 0.001
Blood urea nitrogen 20 mg/dl 1205 (15.8%) 906 (13.5%) 299 (33.4%) <0.001
Creatinine >1.3 mg/dl 436 (5.7%) 333 (5.0%) 103 (11.5%) <0.001
Platelets < 150 000/ml 942 (12.4%) 807 (12.0%) 135 (15.1%) 0.008
Disseminated cancer 2896 (38.0%) 2599 (38.6%) 297 (33.2%) 0.002
Bleeding disorder 255 (3.3%) 214 (3.2%) 41 (4.6%) 0.028
Chemotherapy within 30 days 551 (7.2%) 525 (7.8%) 26 (2.9%) <0.001
ASA class 3 5074 (66.6%) 4352 (64.7%) 722 (80.8%) <0.001
Admitted 1 day before surgery 701 (9.2%) 600 (8.9%) 101 (11.3%) 0.021
Malignant (versus benign) disease 4978 (85.4%) 4364 (84.4%) 614 (93.2%) <0.001
Smokera 1244 (16.3%) 1181 (17.6%) 63 (7.0%) <0.001
Alcohol usea 210 (2.8%) 195 (2.9%) 15 (1.7%) 0.036
Body mass index 30 kg/m2a 2865 (37.6%) 2607 (38.8%) 258 (28.9%) <0.001
Intraoperative factors
Operative time, min, median (range) 220 (7–1029) 223 (7–1029) 204 (30–693) <0.001
Operative time >240 min, n (%) 3283 (43.1%) 2954 (43.9%) 329 (36.8%) <0.001
Any intraoperative transfusion, n (%) 1514 (26.6%) 1319 (26.1%) 195 (29.9%) 0.043
Extent of hepatectomy, n (%) 0.038
Partial 4553 (59.7%) 3994 (59.4%) 559 (62.5%)
Left 802 (10.5%) 701 (10.4%) 101 (11.3%)
Right 1494 (19.6%) 1342 (19.9%) 152 (17.0%)
Extended 772 (10.1%) 690 (10.3%) 82 (9.2%)
Right/extended versus left/partial 0.013
Right/extended, n (%) 2266 (29.7%) 2032 (30.2%) 234 (26.2%)
Left/partial, n (%) 5355 (70.3%) 4695 (69.8%) 660 (73.8%)
Postoperative factors, n (%)
Postoperative pneumonia 274 (3.6%) 219 (3.3%) 55 (6.2%) <0.001
Re-intubation 284 (3.7%) 220 (3.3%) 64 (7.2%) <0.001
Ventilator >48 h 320 (4.2%) 262 (3.9%) 58 (6.5%) <0.001
Renal insufficiency/failure 169 (2.2%) 139 (2.1%) 30 (3.4%) 0.014
Urinary tract infection 301 (3.9%) 252 (3.7%) 49 (5.5%) 0.012
Septic shock 232 (3.0%) 183 (2.7%) 49 (5.5%) <0.001
Any postoperative transfusion 494 (6.5%) 410 (6.1%) 84 (9.4%) <0.001
Venous thromboembolism 210 (2.8%) 176 (2.6%) 34 (3.8%) 0.042
Any severe complication, n (%) 1450 (19.0%) 1236 (18.4%) 214 (23.9%) <0.001
Postoperative LoS, days, median (range) 6 (1–138) 6 (1–120) 7 (1–138) <0.001
Death within 30 days, n (%) 177 (2.3%) 134 (2.0%) 43 (4.8%) <0.001
aThe incidence of these risk factors was lower in the elderly group compared with the non-elderly group.
Not significant: year of operation; sodium; white blood cells; partial thrombin time; total bilirubin; aspartate aminotransferase; alkaline phosphatase; recent sepsis; ascites; steroids;
preoperative open wound; preoperative transfusion; operation in preceding 30 days; chief resident involvement; preoperative weight loss of >10%; other abdominal organ operation;
additional radiofrequency ablation; any surgical site infection or wound disruption; dehiscence; return to operating room, and organ space infection.
Fewer than 0.9% of all patients had the following risk factors and thus these factors were excluded from further analyses: preoperative pneumonia; ascites; varices; preoperative heart
failure; preoperative myocardial infarction; preoperative angina; preoperative dialysis; preoperative transfusion of >4 units; postoperative coma, and postoperative stroke.
COPD, chronic obstructive pulmonary disease; INR, international normalized ratio; ASA, American Society of Anesthesiologists; LoS, length of stay.
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large, multi-institution, nationwide sample of patients, the
current study shows that elderly patients demonstrate higher rates
of severe complications and post-hepatectomy mortality after
severe complications. Although interesting, these data alone do
not help to improve patient care. The aim of this study was to
identify potentially modifiable risk factors that surgeons can use
to improve post-hepatectomy surgical outcomes in elderly
patients. The analysis of this group of elderly patients, which was
largely without overt signs of advanced chronic liver disease,
determined that pulmonary disease, malnutrition and various
aspects of the magnitude of operation, including simultaneous
major operations, transfusion needs and prolonged operative
time, were independent risk factors for major morbidity and
mortality.
To the extent that the patient’s primary disease allows, preha-
bilitation and preoperative outpatient nutritional support may be
modifiable factors that result in fewer complications.28,29 The
issues pertaining to the magnitude of surgery are more difficult to
address. The data from this study suggest that longer and more
complex operations significantly raise the risk for morbidity in
elderly patients. For example, a third of elderly patients suffered at
least one severe complication after right or extended hepatectomy.
These data add to an increasing awareness that the combination of
comorbidities (both known and occult) and older age with diffi-
cult operations is a potentially volatile mixture which synergisti-
cally increases the calculated risk for poor outcomes (Fig. 5).
These data indicate that, when it is oncologically feasible, surgeons
should limit the magnitude of resection and avoid performing
simultaneous major operations (e.g. right hepatectomy combined
with proctectomy) in elderly patients.30
A striking issue uncovered by this analysis concerns the age-
related difference in the facility with which patients can be rescued
after severe complications. Lack of ability to rescue older patients
accounted for the majority of the disparity in 30-day death rates
between elderly and non-elderly patients. Furthermore, in elderly
patients mortality after severe complications rose steeply as the
additive burden of severe complications increased, with patients
suffering one or more, two or more and three or more complica-
tions subject to mortality rates of 20.1%, 31.7% and 46.3%,
respectively. These data expose an underlying frailty in elderly
patients which may not be initially apparent in the clinic, but is
quickly revealed in the setting of inpatient severe complications
Figure 1 Proportions of patients aged < 75 years and 75 years in
whom operative time was >240 min and undergoing right or
extended hepatectomy, showing that operative time and magnitude
of hepatectomy are lower in elderly patients
Figure 2 Proportions of patients affected by severe complications across all extents of hepatectomy, showing that greater age increases the
risk for severe complications
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and ultimately impairs recovery to the point of death. The impli-
cation of these findings, for both surgeons and hospitals, is that
any improvement in postoperative mortality rates in elderly
patients will depend on hypervigilance in the prevention of, early
detection of and timely intervention upon post-hepatectomy
complications. This knowledge should also be incorporated into
the risk : benefit analysis the surgeon discusses with elderly
patients so that these patients are better informed when they
consent to undergo major hepatectomy.
The intent of this study is not to discourage surgeons from
operating on elderly patients. As most surgeons anticipate that
the number of operations in elderly patients will increase in the
future as a result of the aforementioned population trends, the
purpose of this study is to encourage careful medical workup
Table 2 Factors associated with severe complications in elderly (75 years) hepatectomy patients
Clinical characteristic All elderly patients No severe complications Severe complications P-value
Patients, n (%) 894 (100%) 680 (76.1%) 214 (23.9%)
Preoperative factors, n (%)
Gender, male 484 (54.1%) 354 (52.1%) 130 (60.7%) 0.026
COPD 54 (6.0%) 34 (5.0%) 20 (9.3%) 0.020
Haematocrit < 39% 448 (50.1%) 328 (48.2%) 120 (56.1%) 0.045
AST 30 IU/l 334 (37.4%) 239 (35.1%) 95 (44.4%) 0.015
Alkaline phosphatase >93 IU/l 388 (43.4%) 275 (40.0%) 113 (52.8%) 0.001
INR 1.2 98 (11.0%) 66 (9.7%) 32 (15.0%) 0.032
White blood cells >11 000/mL 48 (5.4%) 30 (4.4%) 18 (8.4%) 0.024
ASA class 4 56 (6.3%) 35 (5.1%) 21 (9.8%) 0.014
Admitted 1 day before surgery 101 (11.3%) 65 (9.6%) 36 (16.8%) 0.003
Malignant (versus benign) disease 614 (93.2%) 472 (92.9%) 142 (94.0%) 0.630
Intraoperative factors
Operative time, min, median (range) 204 (30–693) 188 (30–693) 253 (73–693) <0.001
Operative time >240 min, n (%) 329 (36.8%) 207 (30.4%) 122 (57.0%) <0.001
Any intraoperative transfusion, n (%) 195 (29.9%) 120 (23.8%) 75 (50.3%) <0.001
RBC 2 units, n (%) 142 (21.7%) 79 (15.7%) 63 (42.3%) <0.001
RBC 4 units, n (%) 56 (8.6%) 28 (5.6%) 28 (18.8%) <0.001
Extent of hepatectomy, n (%) <0.001
Partial 559 (62.5%) 447 (65.7%) 112 (52.3%)
Left 101 (11.3%) 77 (11.3%) 24 (11.2%)
Right 152 (17.0%) 102 (15.0%) 50 (23.4%)
Extended 82 (9.2%) 54 (7.9%) 28 (13.1%)
Partial versus left/right/extended, n (%) 559 (62.5%) 447 (65.7%) 112 (52.3%) <0.001
Right/extended versus left/partial <0.001
Right/extended, n (%) 234 (26.2%) 156 (22.9%) 78 (36.4%)
Left/partial, n (%) 660 (73.8%) 524 (77.1%) 136 (63.6%)
Biliary repair/reconstruction, n (%) 57 (6.4%) 30 (4.5%) 27 (12.7%) <0.001
Simultaneous colorectal, n (%) 18 (2.0%) 5 (0.7%) 13 (6.1%) <0.001
Another abdominal organ, n (%) 115 (12.9%) 64 (9.4%) 51 (23.8%) <0.001
Postoperative factors
Postoperative LoS, days, median (range) 7 (1–138) 6 (1–138) 7 (1–73) <0.001
Postoperative LoS 7 days, n (%) 469 (52.5%) 286 (42.1%) 183 (85.5%) <0.001
Death within 30 days, n (%) 43 (4.8%) 0 (0%) 43 (20.1%) <0.001
Not significant: race; year of operation; body mass index; diabetes; smoking status; alcohol use; dyspnoea; preoperative independent function;
preoperative stroke history; previous coronary stent/angioplasty; cardiac surgery; steroids; medical hypertension; surgical peripheral vascular
disease; disseminated cancer; bleeding disorder; chemotherapy within 30 days; sodium; blood urea nitrogen; creatinine; platelets; albumin; partial
thrombin time; total bilirubin; operation in preceding 30 days; chief resident involvement, and preoperative weight loss of >10%.
COPD, chronic obstructive pulmonary disease; AST, aspartate aminotransferase; INR, international normalized ratio; ASA, American Society of
Anesthesiologists; RBC, packed red blood cells; LoS, length of stay.
464 HPB
HPB 2014, 16, 459–468 © 2013 International Hepato-Pancreato-Biliary Association
and optimization of preoperative nutrition, conditioning and
medical issues in the elderly patient population. The unique risk
profile of elderly patients indicates that surgeons need to care-
fully balance the patient’s preoperative issues with the planned
extent of operation. For example, the theoretical cost savings31
achieved by performing a simultaneous proctectomy and major
hepatectomy in one setting may be outweighed by the significant
risks for morbidity and mortality associated with performing
such a combination of procedures in an elderly patient. Although
complex operations technically can be performed with little to
no intraoperative mortality, surgeons should recognize that the
higher incidence and multiplicity of postoperative severe com-
plications, combined with the impaired ability of elderly patients
to recover from physiologic insults, ultimately result in higher
mortality rates.
The limitations of the present study include those typical of
research that uses the NSQIP database to assess hepatobiliary-
specific surgical outcomes. Although they were not designed for
liver surgery,22 the perioperative variables collected by the NSQIP
were sufficient for this study’s broad analysis of post-hepatectomy
morbidity and mortality in elderly patients. In addition, the scale
of the patient cohort (n = 7621) reported in the NSQIP database
allowed for a robust analysis of risk factors for morbidity and
mortality, which is not feasible in smaller single-institution
studies. Studies using national databases such as this are not nec-
essarily better than single-institution studies, which often have
more granular data on patient- and disease-specific variables, as
well as data on longterm outcomes, but multi-institution regis-
tries do offer a window into morbidity and mortality rates that
may be more representative of surgical practice as it occurs
outside major academic institutions that are over-represented in
the medical literature and that publish outcomes that may not be
generalizable.
Another potential limitation of evaluating post-hepatectomy
complications and deaths in the NSQIP dataset is that the data
available do not support the study of events that occur beyond 30
days postoperatively.7,32 Some of the practical endpoints that have
been proposed as additions to the procedure-targeted NSQIP
models for hepatobiliary surgery include 90-day postoperative
morbidity and mortality, return to intended oncologic therapy,
return to baseline or independent function, and quality of life. It is
to be hoped that the inclusion of these more patient-centric end-
points will, in the future, allow clinicians to better characterize the
impact of postoperative complications on longterm outcomes that
are relevant for both surgeons and patients. Despite these limita-
tions, this NSQIP-based study was able to offer a broader ‘real
world’ view of short-term morbidity and mortality in elderly
patients which allowed for the development of specific recommen-
dations regarding risk modification and quality improvement.
In conclusion, elderly patients may experience an overall mor-
tality rate after hepatectomy that is more than twice that of non-
elderly patients. This mortality differential is not completely
explained by the higher rate of severe complications alone.
Because they have less physiologic reserve, elderly patients who
develop severe complications are at much greater risk for post-
hepatectomy death, which reflects their narrow therapeutic
window and low tolerance for adverse events in postoperative
care. These data suggest that, to improve surgical outcomes in
the elderly population, liver surgeons should develop multi-
component strategies that address prehabilitation and rescue
from complications, while limiting the extent and complexity of
resection procedures.
Figure 3 Mortality rates in patients aged < 75 years and 75 years showing that mortality increases with extent of hepatectomy and older
patient age, with the greatest disparity observed after right and extended hepatectomies. Statistical comparison is between right/extended
and partial/left hepatectomies
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Table 3 Factors associated with postoperative death in elderly (75 years) hepatectomy patients
Clinical characteristic All elderly
patients
No death within
30 days
Postoperative death
within 30 days
P-value
Patients, n (%) 894 (100%) 851 (95.2%) 43 (4.8%)
Preoperative factors, n (%)
AST 30 IU/l 334 (37.4%) 310 (36.4%) 24 (55.8%) 0.010
Alkaline phosphatase >93 IU/l 388 (43.4%) 359 (42.2%) 29 (67.4%) 0.001
Total bilirubin >1 116 (13.0%) 104 (12.2%) 12 (27.9%) 0.003
Albumin < 4 g/dl 411 (46.0%) 384 (45.1%) 27 (62.8%) 0.023
INR 1.2 98 (11.0%) 86 (10.1%) 12 (27.9%) <0.001
Haematocrit < 39% 448 (50.1%) 420 (49.4%) 28 (65.1%) 0.044
White blood cells >11 000/ml 48 (5.4%) 41 (4.8%) 7 (16.3%) 0.001
Disseminated cancer 297 (33.2%) 292 (34.3%) 5 (11.6%) 0.002
Weight loss >10% 49 (5.5%) 43 (5.1%) 6 (14.0%) 0.012
ASA class 4 56 (6.3%) 49 (5.8%) 7 (16.3%) 0.005
Admitted 1 day before surgery 101 (11.3%) 90 (10.6%) 11 (25.6%) 0.002
Malignant (versus benign) disease 614 (93.2%) 589 (93.2%) 25 (92.6%) 0.903
Intraoperative factors
Operative time, min, median (range) 204 (30–693) 199 (30–693) 287 (73–567) <0.001
Operative time >240 min, n (%) 329 (36.8%) 301 (35.4%) 28 (65.1%) <0.001
Any intraoperative transfusion, n (%) 195 (29.9%) 178 (28.4%) 17 (63.0%) <0.001
RBC 2 units, n (%) 142 (21.7%) 129 (20.6%) 13 (48.1%) 0.001
RBC 4 units, n (%) 56 (8.6%) 48 (7.7%) 8 (29.6%) <0.001
Extent of hepatectomy, n (%) 0.001
Partial 559 (62.5%) 540 (63.5%) 19 (44.2%)
Left 101 (11.3%) 100 (11.8%) 2 (2.3%)
Right 152 (17.0%) 137 (16.1%) 15 (34.9%)
Extended 82 (9.2%) 74 (8.7%) 8 (18.6%)
Partial versus left/right/extended, n (%) 559 (62.5%) 540 (63.5%) 19 (44.2%) 0.011
Right/extended versus left/partial <0.001
Right/extended, n (%) 234 (26.2%) 211 (24.8%) 23 (53.5%)
Left/partial, n (%) 660 (73.8%) 640 (75.2%) 20 (46.5%)
Biliary repair/reconstruction, n (%) 57 (6.4%) 48 (5.7%) 9 (20.9%) <0.001
Another abdominal organ, n (%) 115 (12.9%) 103 (12.1%) 12 (27.9%) 0.003
Postoperative factors
Any severe complication, n (%) 214 (23.9%) 171 (20.1%) 43 (100%) <0.001
Postoperative LoS, days, median (range) 7 (1–138) 7 (1–138) 10 (1–30) 0.003
Postoperative LoS 8 days, n (%) 329 (36.8%) 304 (35.7%) 25 (58.1%) 0.003
Not significant: race; gender; year of operation; body mass index; diabetes; smoking status; alcohol use; dyspnoea; preoperative independent
function; preoperative stroke history; chronic obstructive pulmonary disease; previous coronary stent/angioplasty; cardiac surgery; steroids; medical
hypertension; surgical peripheral vascular disease; bleeding disorder; chemotherapy within 30 days; operation in preceding 30 days; sodium; blood
urea nitrogen; creatinine; platelets; partial thrombin time; chief resident involvement, and radiofrequency ablation.
AST, aspartate aminotransferase; INR, international normalized ratio; ASA, American Society of Anesthesiologists; RBC, packed red blood cells;
LoS, length of stay.
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